Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10188702 Methods and compositions for treating hypoglycemic disorders

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+290 characters)
Article

Patent abstract

This invention relates to methods of treating and ameliorating congenital and neonatal hyperinsulinism and post-prandial hypoglycemia, comprising the step of administering an antagonist of the Glucagon-Like Peptide-1 (GLP-1) receptor, e.g. a GLP-1 fragment or analog thereof.

Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101887020
Date of Patent
January 29, 2019
0
Patent Application Number
154538230
Date Filed
March 8, 2017
0
Patent Citations Received
‌
US Patent 10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)
0
‌
US Patent 10653753 Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
0
‌
US Patent 10660937 Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)
0
‌
US Patent 10987407 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 10993992 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
0
‌
US Patent 11020484 Buffered formulations of exendin (9-39)
0
‌
US Patent 11617782 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 11622995 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
0
Patent Primary Examiner
‌
Karlheinz R. Skowronek
0
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 12 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11622995 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
0
Edits on 8 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11617782 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 22 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101887020
Date of Patent
January 29, 2019
0
Patent Application Number
154538230
Date Filed
March 8, 2017
0
Patent Citations Received
‌
US Patent 10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)
0
‌
US Patent 10653753 Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
0
‌
US Patent 10660937 Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)
0
‌
US Patent 10987407 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 10993992 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
0
‌
US Patent 11020484 Buffered formulations of exendin (9-39)
0
Patent Primary Examiner
‌
Karlheinz R. Skowronek
0
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11020484 Buffered formulations of exendin (9-39)
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10993992 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39)

Find more entities like US Patent 10188702 Methods and compositions for treating hypoglycemic disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.